Qiagen
Amgen's Lumakras, Vectibix Net FDA Approval in KRAS G12C-Mutant Colorectal Cancer
The FDA also approved Qiagen's Therascreen KRAS RGQ PCR kit as a companion diagnostic to identify KRAS G12C-mutant patients.
FDA Approves Pfizer's Braftovi With Eli Lilly's Erbitux, Chemo in Colorectal Cancer
The agency granted accelerated approval to the regimen as a frontline option for advanced, BRAF V600E-mtuated tumors based on the BREAKWATER trial.
Qiagen, Eli Lilly Collaborate on Alzheimer's Risk Dx Panel
The firms will develop a multiplex PCR panel for the QiaStat-Dx system that detects APOE genotypes.
Qiagen, AstraZeneca Expand CDx Collaboration Beyond Cancer
Under the agreement, Qiagen will develop and validate a genotyping assay using its QiaStat-Dx platform.
Qiagen, Myriad Genetics to Develop Sequencing-Based Homologous Recombination Deficiency Kit
Qiagen will develop and distribute a next-generation sequencing kit-based HRD test outside the US based on Myriad's MyChoice CDx biomarkers.